{"id":2682,"date":"2008-08-06T09:19:16","date_gmt":"2008-08-06T08:19:16","guid":{"rendered":"http:\/\/www.ethicalquote.com\/index.php\/2008\/08\/06\/cameroun-merck-distribue-une-nouvelle-classe-d%e2%80%99antiretrovirauxarv-aux-malades-du-sida\/"},"modified":"2008-08-15T09:27:02","modified_gmt":"2008-08-15T08:27:02","slug":"cameroun-merck-distribue-une-nouvelle-classe-dantiretrovirauxarv-aux-malades-du-sida","status":"publish","type":"post","link":"https:\/\/www.covalence.ch\/index.php\/2008\/08\/06\/cameroun-merck-distribue-une-nouvelle-classe-dantiretrovirauxarv-aux-malades-du-sida\/","title":{"rendered":"Cameroun : Merck distribue une nouvelle classe d\u2019antir\u00e9troviraux(ARV) aux malades du sida"},"content":{"rendered":"<p class=\"MsoNormal\"><a href=\"http:\/\/www.cameroon-info.net\" target=\"_blank\" title=\"080815_merck.jpg\"><img decoding=\"async\" src=\"http:\/\/www.ethicalquote.com\/newTemplate\/wp-content\/uploads\/2008\/08\/080815_merck.jpg\" title=\"080815_merck.jpg\" alt=\"080815_merck.jpg\" align=\"right\" \/><\/a><span style=\"font-size: 9pt; font-family: Arial\" lang=\"FR\">Pour parer au probl\u00e8me de r\u00e9sistance aux ARV dont de plus en plus de patients camerounais font face, les laboratoires Msd (Merck Sharp and Dhome) ont mis sur pied une nouvelle classe d\u2019Arv. Il s\u2019agit du Raltegravir ou Isentress (nom commercial) distribu\u00e9 gratuitement dans les h\u00f4pitaux et Centres de sant\u00e9 du pays. Cette mol\u00e9cule agit en inhibant l\u2019insertion de l\u2019Adn vih1 dans l\u2019Adn humain par l\u2019enzyme int\u00e9grase. En \u00e9vitant \u00e0\u00a0 l\u2019int\u00e9grase d\u2019accomplir cette fonction essentielle, on limite la capacit\u00e9 du virus \u00e0\u00a0 se r\u00e9pliquer et \u00e0\u00a0 infecter de nouvelles cellules. Le v\u00e9ritable probl\u00e8me au Cameroun qui compte plus d\u2019 un million des malades du sida, actuellement, est la transmission des virus r\u00e9sistants. La transmission des souches r\u00e9sistantes aux Arv a de r\u00e9elles cons\u00e9quences cliniques, compromettant la premi\u00e8re ligne th\u00e9rapeutique. Bien que les Arv soient gratuits, ce probl\u00e8me tend \u00e0\u00a0 devenir un probl\u00e8me de sant\u00e9 publique. Raltegravir (comprim\u00e9s) en association avec d\u2019autres m\u00e9dicaments anti-vih, maintient des r\u00e9ductions de la charge virale vih1 et augmente le nombre de CD4 sur 48 semaines de traitement chez des adultes ayant d\u00e9j\u00e0\u00a0 \u00e9t\u00e9 trait\u00e9s. Raltegravir, d\u2019apr\u00e8s Merck, est un comprim\u00e9 de 400 mg \u00e0\u00a0 prendre deux fois par jour, sans contrainte alimentaire. Il n\u2019a pas besoin d\u2019\u00e0\u00aatre am\u00e9lior\u00e9 avec du ritonavir.5.<\/span><\/p>\n<p class=\"MsoNormal\"><span style=\"font-size: 9pt; font-family: Arial\" lang=\"EN-GB\">Message received by Covalence | Country: <\/span><st1:country-region><st1:place><span style=\"font-size: 9pt; font-family: Arial\" lang=\"EN-GB\">Cameroon<\/span><\/st1:place><\/st1:country-region><span style=\"font-size: 9pt; font-family: Arial\" lang=\"FR\"> | Company: <a href=\"http:\/\/www.ethicalquote.com\/newTemplate\/index.php\/ethicalquote\/?value=8\"><\/a><a href=\"http:\/\/www.ethicalquote.com\/newTemplate\/index.php\/ethicalquote\/?value=3\">Merck &amp; Co<\/a><span style=\"color: black\"><\/span> | Source: Journal La Nouvelle Expression \/  <\/span><span style=\"font-size: 9pt; font-family: Arial\" lang=\"FR\">www.cameroon-info.net <\/span><span style=\"font-size: 9pt; font-family: Arial\" lang=\"EN-GB\"> | Correspondent: <\/span><span style=\"font-size: 9pt; font-family: Arial\"><a href=\"mailto:fuldep@yahoo.fr\"><span lang=\"EN-GB\">Barth\u00e9l\u00e9my Kilosho, FULDEP<\/span><\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pour parer au probl\u00e8me de r\u00e9sistance aux ARV dont de plus en plus de patients camerounais font face, les laboratoires Msd (Merck Sharp and Dhome) ont mis sur pied une nouvelle classe d\u2019Arv. Il s\u2019agit du Raltegravir ou Isentress (nom commercial) distribu\u00e9 gratuitement dans les h\u00f4pitaux et Centres de sant\u00e9 du pays. Cette mol\u00e9cule agit&hellip;<\/p>\n","protected":false},"author":665,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"wds_primary_category":0,"wds_primary_post_series":0,"footnotes":""},"categories":[6],"tags":[40],"post_series":[],"class_list":["post-2682","post","type-post","status-publish","format-standard","hentry","category-messages","tag-merck-co","entry","no-media"],"_links":{"self":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/2682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/users\/665"}],"replies":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/comments?post=2682"}],"version-history":[{"count":0,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/2682\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/media?parent=2682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/categories?post=2682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/tags?post=2682"},{"taxonomy":"post_series","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/post_series?post=2682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}